HOME >> BIOLOGY >> NEWS
After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis

y at the University of California in San Francisco, and Alastair Compston, FRCP, Ph.D., Head of the Department of Clinical Neurosciences at the University of Cambridge, U.K. The other team, which focused their search on a set of genes they considered potential risk factors for MS, was co-led by Jonathan Haines, Ph.D., Director of the Center for Human Genetics Research at Vanderbilt University Medical Center in Nashville, Tenn. and Margaret A. Pericak-Vance, Ph.D., Director of the Miami Institute for Human Genomics at the University of Miami. Drs. Hauser, Compston, Haines and Pericak-Vance participated in both studies.

MS typically causes limb weakness, vision loss and problems with coordination, and is the most common disabling neurological disorder of young adults. It's an autoimmune disease, occurring when the body's immune system mistakenly attacks a protective sheath around axons the delicate cables that nerve cells use to connect with each other. Various immunosuppressant drugs can reduce symptoms and slow the disease's course, but most MS patients become increasingly disabled with time.

The trigger for MS is unclear, though there's strong evidence for an interplay between genetic susceptibility and some type of environmental factor. Having a relative, especially an identical twin, with MS increases one's risk of developing the disease. In the mid-1970s, researchers discovered that human leukocyte antigens (HLA) account for some of this genetic susceptibility. HLAs are proteins displayed on all the body's cells to help the immune system distinguish self from non-self. A variant of the HLA-DRB1 gene, now widely accepted as the strongest genetic risk factor for MS, increases the likelihood of getting the disease up to four-fold.

Still, HLA does not fully explain the genetic basis of MS; scientists have long realized that other genes must play a role that has been difficult to detect. Some studies have pointed to other HLA
'"/>

Contact: Daniel Stimson
stimsond@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
29-Jul-2007


Page: 1 2 3 4

Related biology news :

1. After scrutiny, preemie lung treatments turn out to be safe, effective
2. After 2 years, study shows Revlimid patients live longer and remain transfusion free
3. After North Korea test, what can be done to reduce the growing nuclear threat?
4. After insects attack, plants bunker sugars for later regrowth
5. After the Hurricanes
6. After the yeast is gone bacteria continue to develop flavor of sparkling wine
7. After a time-shift, mixed signals from the circadian clock
8. After flu exposure, mild exercise protects mature mice from dying
9. Regulating Californian stem cell research, and more
10. March of Dimes awards $250K prize to stem cell research, reproductive biology pioneers
11. Experimental Biology 2007: Todays Research, Tomorrows Health, April 28-May 2

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/22/2019)... ... October 22, 2019 , ... Greenberg Traurig, LLP’s global ... Deal Making in the Life Sciences Sector,” with German biotech strategy consulting firm, Catenion. ... at Greenberg Traurig’s Tokyo office . , Speakers from Greenberg Traurig and Catenion ...
(Date:10/17/2019)... (PRWEB) , ... October 15, 2019 , ... ... is pleased to announce it made its first appearance on the Houston Business ... growth of 56 percent. , With corporate headquarters in Houston, Modality Solutions ...
(Date:10/15/2019)... ... October 14, 2019 , ... Erchonia, ... today announces its upcoming Business Meeting in Orlando & 18th Annual Golf Tournament. ... in Orlando, near Erchonia’s headquarters in Melbourne. , The first day will kick ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... , ... September 24, 2019 , ... ... cell company, has completed training and site qualification for clinical trial sites and ... recruitment and screening of potential clinical trial participants. , Clinical trial sites are ...
(Date:9/24/2019)... ... ... In the past three years, the National Science Foundation (NSF) has awarded ... of Mines & Technology that expands human understanding of the microbial world. The ... and yet strong layer which is commonly known as a biofilm. , The broad ...
(Date:9/17/2019)... ... 17, 2019 , ... Catalent, a global leader in clinical ... Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials ... On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a ... announces today that the U.S. Patent and Trademark Office (USPTO) and European Patent ... drug class recommendations for hypertension treatment. , The patent applies to Geneticure’s ...
Breaking Biology Technology:
Cached News: